NCT02121054

Brief Summary

The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,527

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 19, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 23, 2014

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 29, 2020

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

7 years

First QC Date

April 21, 2014

Last Update Submit

March 17, 2023

Conditions

Cardiovascular DiseasesCoronary Artery Disease

Keywords

Antiplatelet AgentsDrug Resistance

Outcome Measures

Primary Outcomes (1)

  • Major adverse event

    Major adverse event : overall mortality, cardiovascular mortality, target vessel revascularization

    2 year

Secondary Outcomes (1)

  • Biomarker

    2 year

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with coronary artery disease, Patients with peripheral artery disease

You may qualify if:

  • Age \>20
  • Patients with coronary artery disease
  • Patients with peripheral artery disease

You may not qualify if:

  • Renal dysfunction
  • Hepatic dysfunction
  • Major surgery planned within 1 year
  • Malignant tumor
  • History of gastrointestinal bleeding
  • low or high platelet count

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asan Medical Center

Seoul, Songpa-Gu, South Korea

Location

MeSH Terms

Conditions

Cardiovascular DiseasesCoronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 21, 2014

First Posted

April 23, 2014

Study Start

October 19, 2013

Primary Completion

October 29, 2020

Study Completion

October 29, 2020

Last Updated

March 20, 2023

Record last verified: 2023-03

Locations

KR(1)